Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies, announced today that it...

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™)...

WEFTEC attendees invited to visit booth #4329 learn about solutions to transform aged critical infrastructure into tomorrow's digital landscape BOSTON, Oct. 6, 2022 /PRNewswire/ -- Schneider...

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has been shortlisted for Company of the Year for 2022...

Renibus Therapeutics® ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today announced that management will present a company...

Five-day gathering includes leading medical researchers from Columbia, Johns Hopkins, MAPS, NYU, and Yale, veterans and generals, New York legislators, and leaders of global indigenous communities...

A new SAS-sponsored study by Economist Impact predicts three potential futures for banking, examining the risks and opportunities ahead CARY, N.C., Oct. 5, 2022 /PRNewswire/ -- As disruptive...

DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases...

Opus IVS™, a global diagnostics, ADAS calibration, programming and on-demand remote expert support leader that is innovating the future of safe, complex vehicle repair, announced today the...

Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces that an abstract has been accepted for poster presentation at the Society for...